Klinik für Urologie
Friesenstraße 11
24534 Neumünster
Fax: 04321-405-2009
Mail: ed.kef@sredse.sualk
Medical administration
Dr. med. Klaus Esders (Chefarzt)
Information and services of the department
- Number of inpatient cases: 1.690
- Medical expertiseSpecialist training and additional training
- Nursing expertiseFurther education / academic degrees and additional qualifications
Services search (in the department)
| Illness | Number of cases |
|---|---|
| Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21) | 354 |
| Other disorders of urinary system - Urinary tract infection site not specified (N39.0) | 131 |
| Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) | 102 |
| Calculus of kidney and ureter - Calculus of kidney (N20.0) | 100 |
| Cystitis (N30.0) | 89 |
| Unspecified haematuria (R31) | 86 |
| Hyperplasia of prostate (N40) | 69 |
| Malignant neoplasm of prostate (C61) | 60 |
| Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) | 52 |
| Obstructive and reflux uropathy (N13.3) | 39 |
| Treatment | Number |
|---|---|
| Injection or administration of medicines into the urinary bladder (8-132.3) | 714 |
| Insertion, exchange or removal of a ureteral stent (8-137.00) | 434 |
| Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) | 187 |
| Insertion, exchange or removal of a ureteral stent (8-137.10) | 141 |
| (9-984.7) | 141 |
| Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) | 119 |
| Exchange or removal of a tube (catheter) in the kidney for draining urine through the abdominal wall (8-138.0) | 108 |
| (9-984.8) | 104 |
| Dilatation of the ureters during an operation or endoscopy (5-560.2) | 92 |
| (8-831.00) | 89 |
Hospital information and services for all specialist departments
Further information
- External quality assurance according to state law
No participation
| No. | Explanation |
|---|---|
| CQ06 | |
| CQ01 |
| Number | Group |
|---|---|
| 161 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
| 95 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
| 67 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
| Job | Explanation |
|---|---|
| Editors of scientific journals/textbooks | |
| Project-related cooperation with colleges and universities | Hochschulstandort Neumünster |
| Student training (clinical traineeship / internship year) | In Zusammenarbeit mit dem Universitätsklinikum Hamburg Eppendorf UKE und dem Universitätsklinikum Schleswig-Holstein - Campus Kiel. |
| Participation in multi-centre Phase I/II studies | Phase II HD 21 Hodgkin Lymphom, Phase II FOOTPATH, metastasiertes Pankreas-Ca. , Phase II CIRCULATE (AIO-KRK-0217) Colon-Ca. , Phase II ALTERNATIVE-C, Follikuläres Lymphom , Phase II GOAL II, rezidivierten/refraktärem aggressivem Lymphom , Phase II LUCAS, MDS (Myelodysplastisches Syndrom) |
| Participation in multi-centre phase III/IV studies | Phase III: CZAR-1, Morbus Waldenström, ESCALADE, DLBCL, FIRE-9-PORT/AIO, metastasiertes Kolorektal-Ca. Phase IV: VeRVe - CLL, INGA – fortgeschrittenes / metastasiertes Adeno-Ca. Magen, AEG oder Ösophagus, BERING CRC- (Metastasiertes Kolorektal-Ca.), FINN - NSCLC (nicht-kleinzelliges Lungen-Ca.) |
| Initiation and management of uni-centric/multi-centric clinical/scientific studies | |
| Lectureships / teaching posts at colleges and universities | |
| Doctoral supervision | |
| Lectureships / teaching posts at universities of applied sciences |
| No. | Training in other healing professions | Comment |
|---|---|---|
| HB10 | Midwife (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
| HB13 | Medical technical assistant for functional diagnostics (MTAF) (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
| HB09 | Speech therapist (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
| HB07 | Surgical technical assistant (m/f) | |
| HB15 | Anaesthesia technical assistant (m/f) | |
| HB19 | Nursing professionals | 65 Ausbildungsplätze |
| HB17 | Auxiliary nurse (m/f) | 25 Ausbildungsplätze |
| HB03 | Physical therapist / physiotherapist (m/f) | Absolvierung des obligatorischen Praktikums im FEK. |
| HB06 | Occupational therapist (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
| HB05 | Medical technical radiology assistant (MTRA) (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
| HB12 | Medical technical laboratory assistant (MTLA) (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
| HB16 | Dietician (m/f) | Absolvierung des obligatorischen Praktikums im FEK |
Günter Humpe-Waßmuth
Patientenombudsmann
Friesenstraße 11
24534 Neumünster
Phone:
04321
-405-2223
Mail:
ed.kef@aw-epmuh
Tanja Goos
Beschwerdemanagerin
Friesenstraße 11
24534 Neumünster
Phone:
04321
-405-2222
Mail:
ed.kef@soog.ajnat
Andrea Vollert
Leitung Stabsstelle Qualitäts- und Risikomanagement
Friesenstraße 11
24534 Neumünster
Phone:
04321
-405-1004
Mail:
ed.kef@trellov.aerdna
PD Dr. med. Andrea Pace
Ärztlicher Direktor, Chefarzt Gastroenterologie
Friesenstraße 11
24534 Neumünster
Phone:
04321
-405-7041
Mail:
ed.kef@ecap.aerdna
Malte Dobin
Leitung Apotheke / Ansprechpartner Arzneimitteltherapiesicherheit
Friesenstraße 11
24534 Neumünster
Phone:
04321
-405-3600
Mail:
ed.kef@nibod.etlam